查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1729239

全球 CBD 消费者健康市场规模研究，按产品（医疗 OTC 产品、保健品）、配销通路（线上商店、零售商店、零售药局）和区域预测 2022-2032

Global CBD Consumer Health Market Size study, by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online Stores, Retail Stores, Retail Pharmacies), and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球 CBD 消费者健康市场价值约为 190.5 亿美元，预计在 2024-2032 年预测期内将以超过 16.20% 的惊人复合年增长率增长。大麻二酚 (CBD) 消费者保健产品市场已迅速从小众健康趋势发展成为主流治疗类别。 CBD 因其非精神活性益处而受到认可，它具有缓解多种疾病（从慢性疼痛和焦虑到失眠和发炎性疾病）的潜力，在全球范围内获得了广泛的关注。消费者越来越多地转向整体和植物衍生的替代品，这使得 CBD 成为现代自我照顾的基石。随着主要市场（尤其是北美和欧洲）的监管框架逐渐放鬆，含有 CBD 的非处方药和营养保健品的涌入正在重塑医疗保健零售格局。

CBD 消费者健康领域的爆炸性成长轨迹受到文化接受、立法进步和消费者对个人化健康的需求等因素的推动。越来越多的临床证据支持大麻二酚在解决急性和慢性健康问题方面的安全性和有效性，这刺激了研发投资和产品创新。同时，CBD 产品製造商、製药公司和零售商之间的策略合作伙伴关係正在加速高品质配方的可用性和可见性。然而，市场并非没有摩擦。监管分类的模糊性、品质控制差异以及不一致的分销协议继续对更广泛的采用和消费者信任构成挑战，而这些问题正在透过 GMP 认证、第三方测试和更清晰的标籤标准慢慢得到缓解。

数位商务在扩大市场覆盖范围方面发挥关键作用。线上管道提供谨慎的访问、广泛的产品组合和教育资源，正在成为主要的分销方式，尤其是在法律环境不断变化的市场中。同时，由于消费者咨询和医生认可的增加，传统零售业态（如药局和以健康为中心的连锁店）的 CBD 库存正在復苏。这些多通路分销模式使消费者更容易将 CBD 融入日常健康习惯。此外，随着 CBD 在预防性医疗保健和生活方式管理中占据一席之地，各公司正在实现产品组合多样化，包括软糖、酊剂、外用药膏、胶囊和饮料等形式，每种形式都针对特定的健康结果进行客製化。

技术融合也正在催化创新。现在，人工智慧个人化工具正在帮助品牌根据健康目标和代谢状况开发以消费者为中心的产品。此外，水溶性CBD製剂和奈米乳液技术的出现提高了生物利用度，增强了治疗效果。新创公司和传统企业都在投资永续采购、有机认证和清洁标籤品牌，以满足挑剔的消费者的期望。随着法律途径不断简化，CBD融入主流医疗保健政策的前景（例如经医学验证的OTC应用的保险报销）可能会引发另一波指数级增长。

从地区来看，受进步的立法、强大的零售基础设施和高度的消费者意识的推动，北美继续主导 CBD 消费者健康市场。欧洲紧随其后，德国和英国等国家在监管清晰度和临床接受度方面处于领先地位。受中产阶级收入不断扩大、城市化进程加快以及日本、韩国和澳洲等国家对天然保健产品需求日益增长的推动，亚太地区预计将在未来十年实现最快的成长。拉丁美洲和中东及非洲虽然目前还处于起步阶段，但透过政府支持的试点计画和消费者对天然药物替代品日益增长的兴趣，正稳步崛起。

目录

第一章：全球 CBD 消费者健康市场执行摘要

  • 全球市场规模及预测（2022-2032）
  • 区域概要
  • 分段总结
    • 副产品（医疗非处方产品、保健食品）
    • 依配销通路（网上商店、零售店、零售药局）
  • 主要趋势
  • 经济衰退的影响
  • 分析师建议与结论

第二章：全球CBD消费者健康市场定义与研究假设

  • 研究目标
  • 市场定义
  • 研究假设
    • 包容与排斥
    • 限制
    • 供给侧分析
      • 可用性
      • 基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性（消费者观点）
    • 需求面分析
      • 监理框架
      • 技术进步
      • 环境考虑
      • 消费者认知与接受度
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第三章：全球CBD消费者健康市场动态

  • 市场驱动因素
    • 对天然和植物疗法的需求不断增长
    • 主要市场逐步放宽监管
    • 数位商务和直接面向消费者模式的扩展
  • 市场挑战
    • 监管模糊性和合规复杂性
    • 品质控制差异和第三方测试差距
    • 供应链限制与原料采购问题
  • 市场机会
    • 奈米乳液和水溶性CBD配方
    • 进入新兴医疗保健和健康市场
    • 与製药和零售连锁店建立策略合作伙伴关係
    • 融入保险报销的OTC项目

第四章：全球CBD消费者健康市场产业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手
    • 波特模型的未来主义方法
    • 波特五力影响分析
  • PESTEL分析
    • 政治的
    • 经济的
    • 社会的
    • 科技
    • 环境的
    • 合法的
  • 最佳投资机会
  • 最佳获胜策略
  • 颠覆性趋势
  • 产业专家观点
  • 分析师建议与结论

第五章：全球 CBD 消费者健康市场规模与预测：按产品（2022-2032 年）

  • 细分仪表板
  • 2022 年和 2032 年医疗 OTC 产品收入趋势分析
  • 2022 年和 2032 年营养保健品收入趋势分析

第六章：全球 CBD 消费者健康市场规模与预测：按配销通路（2022-2032 年）

  • 细分仪表板
  • 2022 年和 2032 年线上商店收入趋势分析
  • 2022 年和 2032 年零售店收入趋势分析
  • 2022 年和 2032 年零售药局收入趋势分析

第七章：全球 CBD 消费者健康市场规模与预测：按地区（2022-2032 年）

  • 北美市场
    • 美国市场
    • 加拿大市场
  • 欧洲市场
    • 英国市场
    • 德国市场
    • 法国市场
    • 西班牙市场
    • 义大利市场
    • 欧洲其他市场
  • 亚太市场
    • 中国市场
    • 印度市场
    • 日本市场
    • 澳洲市场
    • 韩国市场
    • 亚太其他市场
  • 拉丁美洲市场
    • 巴西市场
    • 墨西哥市场
    • 拉丁美洲其他市场
  • 中东和非洲市场
    • 沙乌地阿拉伯市场
    • 南非市场
    • 中东其他地区和非洲市场

第 8 章：竞争情报

  • 重点公司 SWOT 分析
    • Charlotte's Web Holdings, Inc.
    • CV Sciences, Inc.
    • Canopy Growth Corporation
  • 顶级市场策略
  • 公司简介
    • Charlotte's Web Holdings, Inc.
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 市场策略
    • CV Sciences, Inc.
    • Canopy Growth Corporation
    • Aurora Cannabis Inc.
    • Elixinol Wellness Ltd
    • Green Roads CBD
    • Medterra CBD
    • Endoca
    • Irwin Naturals
    • Jazz Pharmaceuticals
    • Tilray Brands, Inc.
    • Isodiol International Inc.
    • CBD American Shaman
    • HempFusion Wellness Inc.
    • Gaia Botanicals, LLC

第九章：研究过程

  • 研究过程概述
    • 资料探勘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
简介目录

Global CBD Consumer Health Market is valued at approximately USD 19.05 billion in 2023 and is anticipated to grow with an impressive CAGR of more than 16.20% over the forecast period 2024-2032. The market for cannabidiol (CBD) consumer health products has rapidly evolved from a niche wellness trend into a mainstream therapeutic category. Recognized for its non-psychoactive benefits, CBD has gained significant traction across the globe for its potential to alleviate a wide range of conditions-ranging from chronic pain and anxiety to insomnia and inflammatory disorders. The increasing shift of consumers toward holistic and plant-derived alternatives has transformed CBD into a cornerstone of modern self-care. As regulatory frameworks across key markets gradually loosen, particularly in North America and Europe, the influx of CBD-infused medical OTC products and nutraceuticals is reshaping the healthcare retail landscape.

The explosive growth trajectory of the CBD consumer health sector is being powered by a confluence of cultural acceptance, legislative progress, and consumer demand for personalized wellness. An expanding body of clinical evidence supporting the safety and efficacy of cannabidiol in addressing both acute and chronic health concerns has spurred R&D investments and product innovation. Meanwhile, strategic partnerships between CBD product manufacturers, pharmaceutical companies, and retailers are accelerating the availability and visibility of high-quality formulations. However, the market is not without friction. Ambiguities in regulatory classification, quality control disparities, and inconsistent distribution protocols continue to challenge broader adoption and consumer trust-issues that are slowly being mitigated through GMP certifications, third-party testing, and clearer labeling standards.

Digital commerce is playing a pivotal role in amplifying the market's reach. Online channels, which offer discreet access, wide product portfolios, and educational resources, are becoming the primary mode of distribution, especially in markets with evolving legal environments. In parallel, traditional retail formats-such as pharmacies and health-focused chains-are witnessing a resurgence in CBD stocking due to increased consumer inquiries and physician endorsements. These multi-channel distribution models are making it easier for consumers to incorporate CBD into their daily wellness routines. Moreover, as CBD finds its place in preventive healthcare and lifestyle management, companies are diversifying portfolios to include formats like gummies, tinctures, topical creams, capsules, and beverages, each tailored to specific health outcomes.

Innovation is also being catalyzed by technological integration. AI-enabled personalization tools are now helping brands develop consumer-centric products based on health goals and metabolic profiles. Furthermore, the emergence of water-soluble CBD formulations and nanoemulsion technologies has improved bioavailability, enhancing therapeutic efficacy. Startups and legacy players alike are investing in sustainable sourcing, organic certifications, and clean-label branding to meet the expectations of discerning consumers. As legal pathways continue to streamline, the prospect of CBD integration into mainstream healthcare policies-such as insurance reimbursement for medically validated OTC applications-could unlock yet another wave of exponential growth.

Regionally, North America continues to dominate the CBD consumer health market, driven by progressive legislation, strong retail infrastructure, and high consumer awareness. Europe is following closely, with countries like Germany and the UK leading in terms of regulatory clarity and clinical acceptance. Asia Pacific is poised for the fastest growth over the next decade, buoyed by expanding middle-class income, increasing urbanization, and a growing appetite for natural health products across countries like Japan, South Korea, and Australia. Latin America and the Middle East & Africa, while currently nascent, are steadily emerging through government-backed pilot programs and rising consumer interest in natural medicine alternatives.

Major market player included in this report are:

  • Charlotte's Web Holdings, Inc.
  • CV Sciences, Inc.
  • Elixinol Wellness Ltd
  • Canopy Growth Corporation
  • Aurora Cannabis Inc.
  • Green Roads CBD
  • Medterra CBD
  • Endoca
  • Irwin Naturals
  • Jazz Pharmaceuticals
  • Tilray Brands, Inc.
  • Isodiol International Inc.
  • CBD American Shaman
  • HempFusion Wellness Inc.
  • Gaia Botanicals, LLC

The detailed segments and sub-segment of the market are explained below:

By Product

  • Medical OTC Products
  • Nutraceuticals

By Distribution Channel

  • Online Stores
  • Retail Stores
  • Retail Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global CBD Consumer Health Market Executive Summary

  • 1.1. Global Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product (Medical OTC Products, Nutraceuticals)
    • 1.3.2. By Distribution Channel (Online Stores, Retail Stores, Retail Pharmacies)
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global CBD Consumer Health Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global CBD Consumer Health Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Growing Demand for Natural & Plant-Derived Remedies
    • 3.1.2. Progressive Regulatory Relaxation in Key Markets
    • 3.1.3. Expansion of Digital Commerce & Direct-to-Consumer Models
  • 3.2. Market Challenges
    • 3.2.1. Regulatory Ambiguity & Compliance Complexity
    • 3.2.2. Quality Control Disparities & Third-Party Testing Gaps
    • 3.2.3. Supply-Chain Constraints and Ingredient Sourcing Issues
  • 3.3. Market Opportunities
    • 3.3.1. Nanoemulsion & Water-Soluble CBD Formulations
    • 3.3.2. Entry into Emerging Healthcare & Wellness Markets
    • 3.3.3. Strategic Partnerships with Pharma and Retail Chains
    • 3.3.4. Integration into Insurance-Reimbursed OTC Programs

Chapter 4. Global CBD Consumer Health Market Industry Analysis

  • 4.1. Porter's Five Forces Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's Model
    • 4.1.7. Porter's Five Forces Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunities
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspectives
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global CBD Consumer Health Market Size & Forecasts by Product (2022-2032)

  • 5.1. Segment Dashboard
  • 5.2. Medical OTC Products Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.3. Nutraceuticals Revenue Trend Analysis, 2022 & 2032 (USD Billion)

Chapter 6. Global CBD Consumer Health Market Size & Forecasts by Distribution Channel (2022-2032)

  • 6.1. Segment Dashboard
  • 6.2. Online Stores Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.3. Retail Stores Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.4. Retail Pharmacies Revenue Trend Analysis, 2022 & 2032 (USD Billion)

Chapter 7. Global CBD Consumer Health Market Size & Forecasts by Region (2022-2032)

  • 7.1. North America Market
    • 7.1.1. U.S. Market
    • 7.1.2. Canada Market
  • 7.2. Europe Market
    • 7.2.1. UK Market
    • 7.2.2. Germany Market
    • 7.2.3. France Market
    • 7.2.4. Spain Market
    • 7.2.5. Italy Market
    • 7.2.6. Rest of Europe Market
  • 7.3. Asia Pacific Market
    • 7.3.1. China Market
    • 7.3.2. India Market
    • 7.3.3. Japan Market
    • 7.3.4. Australia Market
    • 7.3.5. South Korea Market
    • 7.3.6. Rest of Asia Pacific Market
  • 7.4. Latin America Market
    • 7.4.1. Brazil Market
    • 7.4.2. Mexico Market
    • 7.4.3. Rest of Latin America Market
  • 7.5. Middle East & Africa Market
    • 7.5.1. Saudi Arabia Market
    • 7.5.2. South Africa Market
    • 7.5.3. Rest of Middle East & Africa Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Charlotte's Web Holdings, Inc.
    • 8.1.2. CV Sciences, Inc.
    • 8.1.3. Canopy Growth Corporation
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Charlotte's Web Holdings, Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. CV Sciences, Inc.
    • 8.3.3. Canopy Growth Corporation
    • 8.3.4. Aurora Cannabis Inc.
    • 8.3.5. Elixinol Wellness Ltd
    • 8.3.6. Green Roads CBD
    • 8.3.7. Medterra CBD
    • 8.3.8. Endoca
    • 8.3.9. Irwin Naturals
    • 8.3.10. Jazz Pharmaceuticals
    • 8.3.11. Tilray Brands, Inc.
    • 8.3.12. Isodiol International Inc.
    • 8.3.13. CBD American Shaman
    • 8.3.14. HempFusion Wellness Inc.
    • 8.3.15. Gaia Botanicals, LLC

Chapter 9. Research Process

  • 9.1. Research Process Overview
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes